Just so it's clear. This 1 patient was from a more randomised trial. Helped us to lead into.specific bile duct trial. So original patient 2 years clear no re-lapse. Further more safety profile of recent study has cleared 3 patients on initial cohort, meaning 10 people can now enter study
Ann: Complete Response in MAST Study Maintained Over Two Years, page-34
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
-0.002(10.7%) |
Mkt cap ! $93.33M | |||
| Open | High | Low | Value | Volume |
| 1.3¢ | 1.3¢ | 1.2¢ | $169.9K | 13.68M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 57 | 14924692 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 6817178 | 24 |
View Market Depth
| Last trade - 14.49pm 23/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |